{"transactions":[{"id":878668,"issuer":{"id":4793,"kind":"organization","name":"OPPENHEIMER HOLDINGS INC"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A non-voting common stock","published_at":"2026-02-27T16:09:43.000Z","date":"2026-02-26","kind":"other","planned":false,"acquired":true,"shares":1400,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents a restricted stock award granted under the Oppenheimer Holdings Inc. 2024 Incentive Plan"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a restricted stock award granted under the Oppenheimer Holdings Inc. 2024 Incentive Plan"}],"balance_after":5900,"source":{"system":"sec-edgar","filing":"0001628280-26-012628","document":"wk-form4_1772208581.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791963/000162828026012628/wk-form4_1772208581.xml","form_type":"4"}},{"id":919013,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T11:17:54.000Z","date":"2026-02-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0.395,"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001193125-26-036963","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000119312526036963/ownership.xml","form_type":"4"}},{"id":919012,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T11:17:54.000Z","date":"2026-02-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":1.05,"underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001193125-26-036963","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000119312526036963/ownership.xml","form_type":"4"}},{"id":919011,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T11:17:54.000Z","date":"2026-02-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":1.05,"underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001193125-26-036963","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000119312526036963/ownership.xml","form_type":"4"}},{"id":919010,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T11:17:54.000Z","date":"2026-02-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10230,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":1.05,"underlying":"Common Stock","underlying_shares":10230},"source":{"system":"sec-edgar","filing":"0001193125-26-036963","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000119312526036963/ownership.xml","form_type":"4"}},{"id":919009,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T11:17:54.000Z","date":"2026-02-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20460,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a \"Stock Option\") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an \"Out-of-the-Money Option\"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":1.05,"underlying":"Common Stock","underlying_shares":20460},"source":{"system":"sec-edgar","filing":"0001193125-26-036963","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000119312526036963/ownership.xml","form_type":"4"}},{"id":919008,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T11:17:54.000Z","date":"2026-02-03","kind":"other","planned":false,"acquired":false,"shares":42500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. (\"Purchaser\"), Purchaser completed a tender offer for shares of Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of January 28, 2026, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive (i) $0.088 per share of common stock, net to the seller in cash, without interest (the \"Closing Amount\") plus (ii) one non-tradeable contingent value right, in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. (\"Purchaser\"), Purchaser completed a tender offer for shares of Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of January 28, 2026, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive (i) $0.088 per share of common stock, net to the seller in cash, without interest (the \"Closing Amount\") plus (ii) one non-tradeable contingent value right, in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-036963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000119312526036963/ownership.xml","form_type":"4"}},{"id":919007,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T11:17:54.000Z","date":"2026-02-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. (\"Purchaser\"), Purchaser completed a tender offer for shares of Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of January 28, 2026, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive (i) $0.088 per share of common stock, net to the seller in cash, without interest (the \"Closing Amount\") plus (ii) one non-tradeable contingent value right, in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. (\"Purchaser\"), Purchaser completed a tender offer for shares of Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of January 28, 2026, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive (i) $0.088 per share of common stock, net to the seller in cash, without interest (the \"Closing Amount\") plus (ii) one non-tradeable contingent value right, in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration."}],"balance_after":42500,"source":{"system":"sec-edgar","filing":"0001193125-26-036963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000119312526036963/ownership.xml","form_type":"4"}},{"id":962815,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-18T15:13:42.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":43000,"price":0.112,"value":4816.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.1111 to $0.1130. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":65000,"source":{"system":"sec-edgar","filing":"0001193125-25-324476","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000119312525324476/ownership.xml","form_type":"4"}},{"id":1114554,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-11T06:01:07.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in 36 equal monthly installments from the grant date, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":0.395,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-25-084619","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000095017025084619/ownership.xml","form_type":"4"}},{"id":1290175,"issuer":{"id":4793,"kind":"organization","name":"OPPENHEIMER HOLDINGS INC"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A non-voting common stock","published_at":"2025-01-31T17:48:23.000Z","date":"2025-01-30","kind":"other","planned":false,"acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted under the Oppenheimer Holdings Inc. 2014 Incentive Plan"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a restricted stock award granted under the Oppenheimer Holdings Inc. 2014 Incentive Plan"}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001775404-25-000002","document":"wk-form4_1738345697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791963/000177540425000002/wk-form4_1738345697.xml","form_type":"4"}},{"id":1486057,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T16:17:56.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the Restricted Stock Units shall vest on a quarterly basis from June 6, 2024 until the earlier of (i) the first anniversary of the date of grant and (ii) the date of the issuer's next annual stockholder meeting, in each case, subject to the reporting person's continuous service as of each such date."}],"balance_after":108000,"source":{"system":"sec-edgar","filing":"0000950170-24-070668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000095017024070668/ownership.xml","form_type":"4"}},{"id":1668785,"issuer":{"id":4793,"kind":"organization","name":"OPPENHEIMER HOLDINGS INC"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A non-voting common stock","published_at":"2024-01-29T19:33:43.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted under the Oppenheimer Holdings Inc. 2014 Incentive Plan"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a restricted stock award granted under the Oppenheimer Holdings Inc. 2014 Incentive Plan"}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001775404-24-000002","document":"wk-form4_1706556814.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791963/000177540424000002/wk-form4_1706556814.xml","form_type":"4"}},{"id":1720991,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-05T19:03:09.000Z","date":"2023-12-01","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":2.1789,"value":65367.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1489 to $2.180 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":63000,"source":{"system":"sec-edgar","filing":"0001209191-23-057553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919123057553/doc4.xml","form_type":"4"}},{"id":1861714,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-08T21:02:20.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the Restricted Stock Units shall vest on each of September 6, 2023, December 6, 2023, March 6, 2024 and the date which is the earlier of June 6, 2024 and the 2024 annual stockholder meeting, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001209191-23-035597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919123035597/doc4.xml","form_type":"4"}},{"id":2194214,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-04T20:36:38.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":true,"shares":20460,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":20460,"derivative":{"exercise_price":1.05,"expiration_date":"2029-05-12","underlying":"Common Stock","underlying_shares":20460},"source":{"system":"sec-edgar","filing":"0001209191-22-044461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919122044461/doc4.xml","form_type":"4"}},{"id":2194213,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-04T20:36:38.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":false,"shares":20460,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":10,"expiration_date":"2029-05-12","underlying":"Common Stock","underlying_shares":20460},"source":{"system":"sec-edgar","filing":"0001209191-22-044461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919122044461/doc4.xml","form_type":"4"}},{"id":2194212,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-04T20:36:38.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":true,"shares":10230,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":10230,"derivative":{"exercise_price":1.05,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":10230},"source":{"system":"sec-edgar","filing":"0001209191-22-044461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919122044461/doc4.xml","form_type":"4"}},{"id":2194211,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-04T20:36:38.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":false,"shares":10230,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":44.02,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":10230},"source":{"system":"sec-edgar","filing":"0001209191-22-044461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919122044461/doc4.xml","form_type":"4"}},{"id":2194210,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-04T20:36:38.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":true,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":16500,"derivative":{"exercise_price":1.05,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-044461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919122044461/doc4.xml","form_type":"4"}},{"id":2194209,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-04T20:36:38.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":false,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":19.7,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-044461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919122044461/doc4.xml","form_type":"4"}},{"id":2194208,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-04T20:36:38.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":true,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an initial grant of 16,500 Options granted on June 3, 2022 that vests as follows: One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":16500,"derivative":{"exercise_price":1.05,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-044461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919122044461/doc4.xml","form_type":"4"}},{"id":2194207,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-04T20:36:38.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":false,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an initial grant of 16,500 Options granted on June 3, 2022 that vests as follows: One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":0,"derivative":{"exercise_price":1.22,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-044461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919122044461/doc4.xml","form_type":"4"}},{"id":2239851,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T21:20:10.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of Options granted to directors under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":16500,"derivative":{"exercise_price":1.22,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-034929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919122034929/doc4.xml","form_type":"4"}},{"id":2680388,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T19:18:12.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12th) of the shares subject to the Option shall vest on July 3, 2021 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":16500,"derivative":{"exercise_price":19.7,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-21-038426","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919121038426/doc4.xml","form_type":"4"}},{"id":2834991,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T07:51:10.000Z","date":"2021-02-19","kind":"purchase","acquired":true,"shares":6500,"price":22.86,"value":148590.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-21-013624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919121013624/doc4.xml","form_type":"4"}},{"id":3119838,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T18:25:03.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":10230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12th) of the shares subject to the Option shall vest on July 4, 2020 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":10230,"derivative":{"exercise_price":44.02,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":10230},"source":{"system":"sec-edgar","filing":"0001209191-20-034791","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919120034791/doc4.xml","form_type":"4"}},{"id":3298529,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-29T16:31:40.000Z","date":"2020-01-28","kind":"purchase","acquired":true,"shares":6500,"price":45.5,"value":295750.0,"ownership":{"direct":true},"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001209191-20-005367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919120005367/doc4.xml","form_type":"4"}},{"id":3525498,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":64351,"kind":"person","name":"Kanter Stacy J.","position":1,"cik":"0001775404","reported_name":"Kanter Stacy J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-15T17:08:46.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":20460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36th) of the shares subject to the Option shall vest each month commencing on June 13, 2019, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":20460,"derivative":{"exercise_price":10,"expiration_date":"2029-05-12","underlying":"Common Stock","underlying_shares":20460},"source":{"system":"sec-edgar","filing":"0001209191-19-030074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697532/000120919119030074/doc4.xml","form_type":"4"}}]}